Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease

Hagemann, PhD, T. L., and A. Messing, VMD, PhD. Suppression of GFAP Toxicity by AlphaB-Crystallin in Mouse Models of Alexander Disease.
Hagemann, T. L., Boelens, W. C., Wawrousek, E. F., & Messing, A. (2009). Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Human molecular genetics, 18(7), 1190–1199. https://doi.org/10.1093/hmg/ddp013